← All stocks

Rein Therapeutics, Inc.

RNTX Net buying
CIK 0001420565 #4552 in the set updated 19 Sep 2026
Bought (12 mo)
$625.62K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$625.62K
+$625.62K against sales at will

By person

3 insiders · 10 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Voss Capital, LP entity
10% owner
$551.06K (5)
+$551.06K
926,441
$992.03K
+79.5%
VON RICKENBACH JOSEF H
Director
$49.56K (4)
+$49.56K
62,514
$66.94K
+304.5%
WINDSOR JAMES BRIAN
See Remarks
$25.00K (1)
+$25.00K
27,207
$29.13K
+1,406%

No percentages here. This company's share count has moved by a factor of 4.0 over the window, from 21,665,941 to 86,267,032 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
VON RICKENBACH JOSEF H
27 May 2026
Director
Buy
4,500
$1.07
$4.82K
VON RICKENBACH JOSEF H
26 May 2026
Director
Buy
23,190
$1.06
$24.47K
VON RICKENBACH JOSEF H
22 May 2026
Director
Buy
15,950
$1.05
$16.71K
VON RICKENBACH JOSEF H
21 May 2026
Director
Buy
3,420
$1.04
$3.56K
WINDSOR JAMES BRIAN
30 Apr 2026
See Remarks
Buy
25,000
$1.00
$25.00K
Voss Capital, LP
14 Nov 2025
10% owner
Buy indirect
104,183
$1.22
$127.59K
Voss Capital, LP
28 Oct 2025
10% owner
Buy indirect
178,392
$1.39
$247.96K
Voss Capital, LP
27 Oct 2025
10% owner
Buy indirect
4,840
$1.37
$6.62K
Voss Capital, LP
27 Oct 2025
10% owner
Buy indirect
92,642
$1.37
$126.92K
Voss Capital, LP
24 Oct 2025
10% owner
Buy indirect
30,176
$1.39
$41.96K

What was left out

Form 4 filings counted 4
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 30 Jun 2017